Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Additional information

The several in vitro tests on o-TDA, usually the 3,4-TDA component, were generally positive in the presence of a metabolic activation system. However the positive responses were always described as marginal, minimal or weak. One reliable, rodent in vivo micronucleus test was negative in bone marrow and also in ascites tumour cells, while another was positive in erythrocytes. Although there was some indication for effects on the testes from a non-standard assay measuring a reduction of murine testicular DNA synthesis after 3,4-TDA, this is not direct and validated evidence of genotoxicity.

On the basis of the positive findings on bacterial and somatic cells in vitro, ortho-TDA is regarded as weakly mutagenic. There is evidence that this is translated to genotoxicity in vivo.

Short description of key information:

Weakly positive in in vitro systems with metabolic activation.

Endpoint Conclusion: Adverse effect observed (positive)

Justification for classification or non-classification

Ortho-TDA can be classified as Mutagen Category 2. according to the criteria described in Regulation (EC) No. 1272/2008.